Molecular Biology of the Cell

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Originally published as MBC in Press, 10.1091/mbc.E08-02-0159 on May 28, 2008

Vol. 19, Issue 8, 3272-3282, August 2008

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Materials
Right arrow All Versions of this Article:
E08-02-0159v1
19/8/3272    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Sayed, D.
Right arrow Articles by Abdellatif, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sayed, D.
Right arrow Articles by Abdellatif, M.

MicroRNA-21 Targets Sprouty2 and Promotes Cellular Outgrowths

Danish Sayed*, Shweta Rane*, Jacqueline Lypowy*,{dagger}, Minzhen He*, Ieng-Yi Chen*, Himanshu Vashistha{ddagger}, Lin Yan*, Ashwani Malhotra{ddagger}, Dorothy Vatner*, and Maha Abdellatif*

*Cardiovascular Research Institute, Department of Cell Biology and Molecular Medicine, and Department of Medicine, and {ddagger}Division of Nephrology, University of Medicine and Dentistry of New Jersey, Newark, NJ 07103

Submitted February 15, 2008; Revised May 19, 2008; Accepted May 21, 2008
Monitoring Editor: Jonathan Chernoff

The posttranscriptional regulator, microRNA-21 (miR-21), is up-regulated in many forms of cancer, as well as during cardiac hypertrophic growth. To understand its role, we overexpressed it in cardiocytes where it revealed a unique type of cell-to-cell "linker" in the form of long slender outgrowths and branches. We subsequently confirmed that miR-21 directly targets and down-regulates the expression of Sprouty2 (SPRY2), an inhibitor of branching morphogenesis and neurite outgrowths. We found that β-adrenergic receptor (βAR) stimulation induces up-regulation of miR-21 and down-regulation of SPRY2 and is, likewise, associated with connecting cell branches. Knockdown of SPRY2 reproduced the branching morphology in cardiocytes, and vice versa, knockdown of miR-21 using a specific ‘miRNA eraser’ or overexpression of SPRY2 inhibited βAR-induced cellular outgrowths. These structures enclose sarcomeres and connect adjacent cardiocytes through functional gap junctions. To determine how this aspect of miR-21 function translates in cancer cells, we knocked it down in colon cancer SW480 cells. This resulted in disappearance of their microvillus-like protrusions accompanied by SPRY2-dependent inhibition of cell migration. Thus, we propose that an increase in miR-21 enhances the formation of various types of cellular protrusions through directly targeting and down-regulating SPRY2.


This article was published online ahead of print in MBC in Press (http://www.molbiolcell.org/cgi/doi/10.1091/mbc.E08-02-0159) on May 28, 2008.

{dagger} Present address: Department of Immunology, Merck & Co, Inc., 125 East Lincoln Avenue, Rahway, NJ 07065.

Address correspondence to: Maha Abdellatif (abdellma{at}umdnj.edu)




This article has been cited by other articles:


Home page
Circ. Res.Home page
E. van Rooij, W. S. Marshall, and E. N. Olson
Toward MicroRNA-Based Therapeutics for Heart Disease: The Sense in Antisense
Circ. Res., October 24, 2008; 103(9): 919 - 928.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2008 by The American Society for Cell Biology. Terms of copyright protection, warranties, and disclaimers.